Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Ensio Norjavaara"'
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
ContextThe use of testosterone enanthate (TE), 50–75 mg intramuscularly (i.m.)/month, for the treatment of boys with delayed puberty or slow progression to induce puberty is the standard of care (SoC) in Sweden. This treatment is empirical and has
Externí odkaz:
https://doaj.org/article/a9f0e5492ee44f5a83751a34700e8df7
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e49404 (2012)
ObjectiveAge at adiposity rebound (AR) is associated with obesity and Type 2 Diabetes in adults. The aim of the present study was to investigate the role of age at AR in adult fat mass, fat distribution and pubertal timing for a Swedish cohort.Patien
Externí odkaz:
https://doaj.org/article/a33ca602e49e47c1a63fccb902375362
Autor:
William V Tamborlane, Lori M Laffel, Naim Shehadeh, Elvira Isganaitis, Michelle Van Name, Jayantha Ratnayake, Cecilia Karlsson, Ensio Norjavaara
Publikováno v:
The Lancet Diabetes & Endocrinology. 10:341-350
Autor:
Thomas, Severin, Solange, Corriol-Rohou, Christina, Bucci-Rechtweg, Kristina, An Haack, Sabine, Fuerst-Recktenwald, Pirkko, Lepola, Ensio, Norjavaara, Martine, Dehlinger-Kremer, Sebastian, Haertter, S Y Amy, Cheung
Publikováno v:
Ther Innov Regul Sci
Therapeutic Innovation & Regulatory Science
Therapeutic Innovation & Regulatory Science
Correction; Early Access: DOI: 10.1007/s43441-020-00152-0 Early Access: APR 2020 Background Pediatric regulations enacted in both Europe and the USA have disrupted the pharmaceutical industry, challenging business and drug development processes, and
Autor:
And Demir, Ulf-Håkan Stenman, Kerstin Albertsson-Wikland, Raimo Voutilainen, Leo Dunkel, Ensio Norjavaara
Publikováno v:
Hormone Research in Paediatrics. 85:301-308
Aims: We studied whether first morning voided (FMV) urinary gonadotropin measurements could be used as a noninvasive alternative to the GnRH test in the assessment of the hypothalamic-pituitary-gonadal function in children. Methods: In a single-cente
Autor:
Sabine Fuerst-Recktenwald, Ensio Norjavaara, Kristina An Haack, Pirkko Lepola, Solange Corriol-Rohou, S.Y. Amy Cheung, Thomas Severin, Christina Bucci-Rechtweg, Sebastian Haertter, Martine Dehlinger-Kremer
Publikováno v:
Therapeutic Innovation & Regulatory Science. 54:1085-1085
The article How is the Pharmaceutical Industry Structured to Optimize Pediatric Drug Development? Existing Pediatric Structure Models and Proposed Recommendations for Structural Enhancement, written by Thomas Severin et al. was originally published e
Publikováno v:
Hormone research in paediatrics. 91(3)
Objective: The aim of this work was to investigate the prevalence of premature thelarche (PT) in 18-month-old girls, and the incidence of clinically evaluated PT for girls aged 18–36 months. Methods: In the prevalence substudy, a prospective popula
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 75:341-344
Immunoassays have been criticized for poor accuracy at low testosterone concentrations. Mass spectrometry (MS) has been proposed as the only reliable method for testosterone determination. The aim of this study was to compare a sensitive testosterone
Autor:
Peter A. Johansson, Folke Sjöberg, Maria Wollbratt, Ensio Norjavaara, Hassan Dorani, Maria Heijer, Hans Ericsson
Publikováno v:
Diabetes Research and Clinical Practice. 98:436-444
To investigate the pharmacodynamics, pharmacokinetics and safety of the glucokinase activator AZD6370 after 1 day of administration under fed and fasted conditions in patients with type 2 diabetes mellitus (T2DM).This was a two-part study. In Part A,
Publikováno v:
Hormone research in paediatrics. 87(5)
Background: Early onset of breast development in a young girl is usually a benign and isolated prepubertal condition, i.e., premature thelarche (PT), but can sometimes be progressive and the first sign of pubertal precocity (PP). Serum 17β-estradiol